Pescatello of CURE Comments on Signing of CT Stem Cell Bill
FARMINGTON, Conn., June 15 /PRNewswire/ -- This afternoon Governor Jodi M. Rell of Connecticut signed into law legislation supporting embryonic stem cell research and earmarking $100 million in funding for such research. CURE (Connecticut United for Research Excellence), the state bioscience organization, was an important resource in researching and drafting the legislation and the catalyst that brought together the coalition that worked for its passage. Paul Pescatello, president and CEO of CURE, responded to the signing of the bill as follows: "This is a great day for Connecticut bioscience. Enactment of this legislation marks a significant step forward for those suffering from a host of diseases and conditions. It is also a further step toward attracting substantial investment and high-paying jobs to Connecticut. "With President Bush set to veto any expansion of federally funded embryonic stem cell research, it will be up to the states and to private investors to fund additional research in the area. By signing this bill into law, Governor Rell has catapulted Connecticut into the vanguard as a state that not only welcomes embryonic stem cell research but supports it financially. "I'm proud to represent bioscience in a state where the Governor and legislators on both sides of the aisle are so willing to work together to do the right thing."